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Yersinia spp. cause gastroenteritis and the
plague, representing historically devastating
pathogens that are currently an important bio-
defense and antibiotic resistance concern. A
critical virulencedeterminant is theYersiniapro-
tein kinase A, or YpkA, a multidomain protein
that disrupts the eukaryotic actin cytoskeleton.
Here we solve the crystal structure of a YpkA-
Rac1 complex and find that YpkA possesses
a Rac1 binding domain that mimics host guani-
dine nucleotide dissociation inhibitors (GDIs) of
the Rho GTPases. YpkA inhibits nucleotide ex-
change in Rac1 and RhoA, and mutations that
disrupt the YpkA-GTPase interface abolish this
activity in vitro and impair in vivo YpkA-induced
cytoskeletal disruption. In cell culture experi-
ments, the kinase and the GDI domains of YpkA
act synergistically to promote cytoskeletal dis-
ruption, and a Y. pseudotuberculosis mutant
lacking YpkA GDI activity shows attenuated vir-
ulence in amouse infection assay.We conclude
that virulence inYersiniadepends strongly upon
mimicry of host GDI proteins by YpkA.
INTRODUCTION
Nearly 200 million people are estimated to have died in the
plague epidemics that devastated the ancient world (Perry
and Fetherston, 1997), and the successful weaponization
of plague in the former Soviet Union bioweapons program
has made this pathogen a primary biodefense concern
(Henderson, 1999; Inglesby et al., 2000). Additional med-
ical concerns arise from the evolution of multidrug resis-
tant strains of the plague bacterium that have been
reported in several locations from patient isolates (Gali-
mand et al., 1997; McCormick, 1998). The plague is
caused by the bacterial pathogen Yersinia pestis, which,along with the food-borne agents of gastroenteritis, Y. en-
terocolitica, and Y. pseudotuberculosis, shares the highly
conserved Yersinia virulence plasmid, or pYV, which is
necessary to cause disease (Cornelis et al., 1998). This
plasmid harbors numerous genes, a large number of
which are associated with a type III protein secretion sys-
tem (T3SS) that confers the ability of diverse pathogens to
deliver virulence factors into host cells (Gala´n and Collmer,
1999). The translocated virulence factors of Yersinia in-
clude a protein tyrosine phosphatase, a cysteine prote-
ase, and a GTPase-activating protein, among others,
and collaborate to disrupt and impair the normal cytoskel-
etal regulation in macrophages and polymorphonuclear
neutrophils (PMNs) to achieve an antiphagocytic effect
(Viboud and Bliska, 2005; Aepfelbacher et al., 1999;
Aepfelbacher, 2004; Cornelis, 2000, 2002).
An important virulence factor of Yersinia spp. is the
Yersinia protein kinase A, or YpkA (also called YopO in
Y. enterocolitica), a substrate of the T3SS, which was first
identified through its important contribution to disease
progression and a region of sequence homology to
eukaryotic serine/threonine kinases (Galyov et al., 1993).
Y. pseudotuberculosis mutants with disruptions in YpkA
have shown severely attenuated virulence in mouse infec-
tion models (Galyov et al., 1993, 1994). YpkA is an 82 kDa
multidomain protein, which, in addition to the protein
kinase, possesses a domain that binds to the small
GTPases RhoA and Rac1, a domain required for activation
by actin, and a relatively uncharacterized N-terminal
domain (Barz et al., 2000; Dukuzumuremyi et al., 2000;
Galyov et al., 1993, 1994; Hakansson et al., 1996; Juris
et al., 2000).
In cultured cells, YpkA appears to function primarily in
disrupting the host actin cytoskeleton (Dukuzumuremyi
et al., 2000; Ha¨kansson et al., 1996; Juris et al., 2000).
Cells transfected with YpkA, or exposed to strains of Yer-
sinia preferentially translocating YpkA over other virulence
factors, lose their actin stress fibers and tend to round up
and detach upon prolonged exposure (Ha¨kansson et al.,
1996; Juris et al., 2000; Nejedlik et al., 2004). Interestingly,
this effect appears to be only partially associated with the
kinase activity, as mutations in the active site attenuate,Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc. 869
Figure 1. Overall Structure of the YpkA-Rac1 Complex
(A) 2:2 YpkA:Rac1 contents of the asymmetric unit shown as ribbon diagrams. The two separate contacts of YpkA to Rac1 are shown, as is the
nucleotide present, GDP.
(B) A Ribbon diagram of YpkA (434–732) is shown and structural elements labeled. The domain break between the N-terminal GTPase binding domain
and the C-terminal actin activation domain is indicated by the divide between the two domain labels.
(C) Sequence-structural analysis of YpkA (434–732). Secondary structure for given residues is indicated above the sequence. The relative solubility of
each residue in the structure is denoted by a colored box beneath it, spanning dark blue (solvent exposed) to white (buried from solvent). The residues
involved in each charged patch of YpkA are labeled in violet and red for basic and acidic, respectively. Disordered regions are shown in yellow.but do not abolish, cytoskeletal alterations, and large in-
ternal deletions in the protein that are C terminal to the ki-
nase domain are unable to cause cytoskeletal disruptions
(Dukuzumuremyi et al., 2000; Juris et al., 2000). YpkA lo-
calizes to the plasma membrane in cultured cells (Dukuzu-
muremyi et al., 2000; Ha¨kansson et al., 1996; Nejedlik
et al., 2004), and mutations in the protein that abolish bind-
ing to the Rho GTPases do not affect membrane localiza-
tion (Dukuzumuremyi et al., 2000).
Biochemically, the kinase activity of YpkA is regulated in
a host dependent fashion (Barz et al., 2000; Dukuzumure-
myi et al., 2000; Juris et al., 2000). Recombinant and Yer-
sinia-secreted YpkA are inactive but are activated in the
presence of heat-sensitive host cell extract (Barz et al.,
2000; Dukuzumuremyi et al., 2000; Juris et al., 2000), and
in particular in the presence of actin alone (Juris et al.,
2000). A 20 amino acid peptide at the COOH terminus of
YpkA was shown by deletion mutagenesis to be critical
for YpkA binding to actin and for kinase autophosphoryla-
tion in vitro (Juris et al., 2000). Therefore, like many eukary-
otic protein kinases, the Yersinia kinase appears to interact
with and be dependent on several regulatory elements in
order to achieve full activity (Huse and Kuriyan, 2002).
We have solved the high-resolution crystal structure of
the Rho-GTPase binding domain of YpkA with its small
GTPase host target Rac1. Analysis of this structure and
biochemical data reveals that YpkA mimics host guani-
dine nucleotide dissociation inhibitors (GDIs) for the Rho870 Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc.family of small GTPases. This interaction with Rac1 is
critical for the cytoskeletal disruption induced by YpkA in
cell culture and is also crucial for virulence in mice.
RESULTS
Overall Structure of the YpkA-Rac1 Complex
A C-terminal region of YpkA, residues 434–732 (Figure S1),
is highly soluble and binds to Rac1 and RhoA, although, in
agreement with previous studies (Barz et al., 2000; Duku-
zumuremyi et al., 2000), not to Cdc42 (Figures S2, 3D, and
3E). Although YpkA (434–732) and Rac1 form a dimer in
solution (Figure S2), the complex crystallized as a 2:2
packing (YpkA:Rac1) in the asymmetric unit with a non-
crystallographic 2-fold axis of symmetry (Figure 1A). Each
molecule of YpkA (434–732) therefore makes contacts
(‘‘A’’ and ‘‘B’’) to two different Rac1 molecules (Figure 1A).
Contact A interacts nearly exclusively with the regulatory
Switch I and Switch II regions of the GTPase, whereas
Contact B interacts with two C-terminal helices adjacent
to the RhoGTPase ‘‘insertion’’ (relative to the Ras-family
small GTPases), distal to the nucletotide and Switch re-
gions. Four facts argue for Contact A being the biologically
relevant interaction: (1) it has nearly twice the buried sur-
face area as Contact B, (2) it contacts the critical Switch
I and Switch II regions of Rac1, whereas Contact B does
not, (3) mutations of Contact A disrupt YpkA-Rac1 interac-
tions, whereas mutations in Contact B do not (see below),
Figure 2. The YpkA-Rac1 Interface
(A) Ribbon diagram view of the Contact A interaction between YpkA and Rac1. Switch I (yellow) and Switch II (red) are highlighted, and GDP is noted.
(B) The image in panel (A) rotated by 90 about a horizontal axis.
(C) Close up of the Switch I interactions with the a6 helix of YpkA. Hydrogen bonds are denoted by dashed red lines.
(D) Close up of the Switch II interactions with the a5 and a6 helices of YpkA. Hydrogen bonds are denoted by dashed red lines.
(E) Schematic of the interactions of the a5 and a6 helices of YpkA with Switch I and Switch II of Rac1. Hydrogen bonds are indicated by red lines
between the interacting residues, and hydrophobic interactions are shown with a yellow background.and (4) a heterodimer appears to be the biological unit as
judged by biochemical experiments (Figures 3 and S2).
The overall structure of YpkA (434–732) reveals an elon-
gated, all-helical molecule consisting of two distinct sub-
domains connected by a 65 A˚ long ‘‘backbone’’ or ‘‘linker
helix’’ (Figures 1A and 1B). The N-terminal subdomain
contains most of the sequence-identified, ACC finger-
like repeats that resemble, at the sequence level, ele-
ments required in host factors for small GTPase binding,
whereas the C-terminal subdomain contains the se-
quence implicated in actin activation. The overall surface
of the molecule is highly charged, containing a large basic
patch in the GTPase binding domain and a large acidic
patch in the actin-activation domain (Figure S3).
Despite apparent sequence similarities, the N-terminal
subdomain of YpkA (residues 434–615) does not share
the coiled-coil fold of host ACC fingers, but instead it con-
sists of six helices organized into two three-helix bundles
packed against each other. Each of the bundles is stabi-
lized by hydrophobic zippering in the core, and extensive
hydrophobic packing is observed between the bundles.
The previously identified regions harboring sequence
similarity with ACC fingers (Dukuzumuremyi et al., 2000;
Maesaki et al., 1999a, 1999b) are not involved in the
YpkA-Rac1 interface. The far C-terminal subdomain of
YpkA, containing the polypeptide implicated in actin acti-
vation (residues 705–732, corresponding to helix a10), is
a novel and elongated fold consisting of four helices clus-tered into two pairs that only moderately interact with each
other. The a10 helix (residues 705–730) encompasses the
peptide that had been predicted to play a role in the inter-
action of YpkA with actin, and past work has shown that
the deletion of the region eliminates both the ability of
YpkA to bind to actin and kinase activity (Juris et al.,
2000). This helix forms an integral part of the fold of this
subdomain, contributing a large number of nonpolar
residues to its hydrophobic core.
There are very few conformational changes between
YpkA (434–732) crystallized alone and YpkA (434–732) in
complex with Rac1 (Figure S3). Most differences are
located in the C-terminal subdomain of YpkA and involve
a slight overall displacement in the positioning of the a7
and a8 helices, as well as alterations in the conformation
and relative disorder of solvent exposed loops. Rac1 is
little altered by the binding of YpkA except for in the
Switch regions as discussed below.
The YpkA-Rac1 Interface
YpkA and Rac1 form an interface burying roughly 1600 A˚2
and limited to residues 573–601 of YpkA (spanning the
helices a5 and a6) contacting the key regulatory Switch I
and Switch II regions of Rac1 (Figures 2A–2E). Switch I
and Switch II together create a concave pocket into which
the a6 (backbone) helix of YpkA inserts (Figure 2B), which,
along with the clustering of the Switch II helix with the a5
and a6 helices, cement the interaction tightly.Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc. 871
The Switch I contacts involve a large number of hydro-
phobic, van der Waals interactions with YpkA, as well as
several hydrogen bonds at this surface (e.g., residues
Asp38 [Rac1] and Arg596 [YpkA], Glu599 [YpkA] and
Tyr32 and The35 of Rac1; Figures 2C and 2E). A striking
aspect of this interaction with Switch I is that YpkA con-
tacts the conserved Thr35 residue, which is normally
involved in magnesium ion coordination (Dvorsky and Ah-
madian, 2004), resulting in a stable coordination network
between the side chain of YpkA Glu599, Rac1 Tyr32, the
hydroxyl group of Thr35, its main chain carbonyl oxygen,
the magnesium ion, and the hydroxyl group of Thr17
(Figure 2C).
At Switch II, the molecular interface between YpkA and
Rac1 is quite extensive, forming the largest portion of the
protein-protein interactions (Figures 2A, 2B, 2D, and 2E).
Most of the contacting residues between YpkA and
Rac1 are involved in hydrophobic, van der Waals interac-
tions forming a nonpolar interface between the a5 and a6
helices of YpkA and the a helix and surrounding loops of
Switch II. Residues Leu573, Val577, and Val586 of YpkA,
along with Leu67 and Leu70 of Rac1, contribute signifi-
cantly to this hydrophobic interface, making what resem-
bles a hydrophobic zippering motif between the a5 and a6
helices of YpkA and the helical element of Switch II (Fig-
ures 2A, 2B, and 2D). This interface between the mole-
cules also includes YpkA Pro585 contacting Rac1 Pro73
at one end, ‘‘pinching’’ off the zipper, along with Tyr591,
Asn595, and Ala598 (YpkA) and Trp56 and Asp63
(Rac1), making several van der Waals contacts between
each other and the hydrophobic zippering motif. Addition-
ally, Rac1 Tyr64 makes van der Waals contacts with YpkA
Glu599, possibly helping to position it for the hydrogen
bonding interactions to Tyr32 and Thr35 in the Switch I
region of Rac1 described above. Although the binding
surface is primarily hydrophobic in nature, it is also stabi-
lized by three polar interactions. The main chain carbonyl
oxygen of Rac1 Asp57 forms a hydrogen bond with the
phenol group hydroxyl of YpkA Tyr591, as does the acidic
group of Rac1 Asp63 with the amino group of YpkA
Lys601. Finally, a salt bridge is formed between Rac1
Arg66 and YpkA Asp574 (Figure 2D).
To examine the importance of these contacts to com-
plex stability, we mutated three residues of YpkA at the
Contact A interaction surface and tested the purified pro-
tein for binding to Rac1 and RhoA. The triple mutant con-
sisted of loss-of-contact mutations to alanine (Tyr591Ala,
Asn595Ala, and Glu599Ala). Although these mutations
do not destabilize YpkA itself, they completely abolish
complex formation with both Rac1 and RhoA (Figure 3),
strongly supporting the crystallographic analysis. In con-
trast, mutations in the second binding site in the crystals
(Contact B, Figure 1A) had no effect on complex formation
(Figure 3).
YpkA Mimics Host GDI Proteins
A comparison of the Yersinia YpkA interaction with Rac1
reveals intriguing similarities to the complexes between872 Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc.host cell GDIs and their target Rho family GTPases. An
alignment of the complexes of RhoGDI-1(a)-Rac1 (Grizot
et al., 2001) and RhoGDI-2(LyGDI)-Rac2 (Scheffzek
et al., 2000) with YpkA-Rac1 reveals that the Switch I poly-
peptide adopts a very similar conformation in all of these
structures (Figure 4A). In addition, the residues of Switch
I that make contacts with the host cell GDIs possess
nearly identical conformations in the Rac1 complex with
YpkA (Figure 4C). YpkA even appears to mimic a hallmark
of the RhoGDI-small GTPase interaction by using an
acidic residue to contact Thr35 of the small GTPase to
form a highly stable coordination network involving YpkA
Glu599, the hydroxyl group of Thr35, the carbonyl oxygen
of Thr35 with the magnesium ion, and the hydroxyl oxygen
of Thr17 (Grizot et al., 2001; Scheffzek et al., 2000). This
structural stabilization of Switch I in the GDP bound con-
formation results in an inhibition of nucleotide exchange.
YpkA, therefore, possesses the key contacts seen be-
tween host RhoGDIs and their target GTPases at Switch
I (Figures 4A and 4C).
YpkA contacts many of the same residues in Switch II as
RhoGDI, although the details of the molecular interactions
differ (Figure 4C). For example, the conformation of Switch
II in the YpkA Rac1 structure is different from that seen in
RhoGDI complexes with small GTPases, where Switch II is
found in a conformation nearly identical to the GTP bound
forms of the small G proteins. YpkA instead contacts
these residues in Switch II in such as manner as to stabi-
lize the region in a conformation similar to the structures of
the GTPases bound to GDP. Indeed, both Switch I and
Switch II of Rac1 in the YpkA structure are almost identical
to the crystal structure of RhoA bound to GDP (Wei et al.,
1997), indicating that YpkA acts to lock the small GTPase
in the GDP bound, or physiologically ‘‘off,’’ conformation.
RhoGDIs are so named for their ability to maintain small
GTPases in an ‘‘inactive’’ physiological state, specifically
through the inhibition of nucleotide exchange in the small
GTPases. This inhibition is achieved by stabilizing the co-
ordination of the magnesium ion and preventing both the
ion and the bound GDP/GTP from dissociating (Scheffzek
et al., 2000). This prevents both intrinsic exchange of the
GDP/GTP nucleotide and that catalyzed by guanidine nu-
cleotide exchange factors, or GEFs.
Given the similarities at the structural level with host
RhoGDIs, we therefore examined whether YpkA could in-
hibit the intrinsic and catalyzed exchange of nucleotides
for Rac1, RhoA, and Cdc42. As shown in Figure 5A,
when Rac1, RhoA, or Cdc42 are incubated in the pres-
ence of mant-GTP, a fluorescent nucleotide analog, there
is an increase of fluorescence signal over time, indicating
that increasing amounts of the labeled nucleotide have
been bound (Experimental Procedures). The addition of
YpkA (434–732) results in a marked decrease in nucleotide
exchange for Rac1 and RhoA, but only a modest decrease
for Cdc42 (Figure 5A). In contrast, the triple mutant (Con-
tact A mutant) of YpkA that is impaired in Rac1 and RhoA
binding was unable to inhibit the exchange of GTP
(Figure 5A). Similar results are observed if we challenge
Figure 3. Gel Filtration and Mutagenesis
(A) The gel filtration profile of YpkA (434–732).
The molecular weight standards used in the
column calibration are labeled above the graph
with the arrows indicating their approximate
elution volume. YpkA (434–732) is shown in
blue, Rac1 is shown in red, and the YpkA
(434–732) and Rac1 complex is shown in
orange.
(B) The gel filtration profile of the YpkA (434–
732) Contact A mutant. YpkA (434–732) Con-
tact A mutant in the presence of Rac1 is shown
in red, the YpkA (434–732) and Rac1 complex
is shown in orange, and the elution peak of
YpkA (434–732) is shown in blue. The gel of
fractions containing the eluted material is
overlain on the graph.
(C) The gel filtration profile of the YpkA (434–
732) Contact B mutant. YpkA (434–732) Con-
tact B mutant in the presence of Rac1 is shown
in red, the YpkA (434–732) and Rac1 complex
is shown in orange, and the elution peak of
YpkA (434–732) is shown in blue.
(D) The gel filtration profile of the YpkA (434–
732) interaction with RhoA. YpkA (434–732) in
the presence of RhoA is shown in orange, the
YpkA (434–732) Contact A mutant and RhoA
complex is shown in red, and the elution peak
of YpkA (434–732) is shown in blue. SDS-
PAGE analysis (stained with Coomassie blue)
of fractions containing the material from YpkA
(434–732) and the YpkA (434–732) Contact A
mutant with RhoA are superimposed on the
corresponding chromatograms.
(E) The gel filtration profile of the YpkA (434–
732) interaction with Cdc42. YpkA (434–732)
in the presence of Cdc42 is shown in orange
and the elution peak of YpkA (434–732) is
shown in blue. SDS-PAGE analysis (stained
with Coomassie blue) of fractions containing
the material from YpkA (434–732) and Cdc42
is superimposed on the chromatogram.the system with a potent GEF, Salmonella SopE (Buch-
wald et al., 2002; Friebel and Hardt, 2000; Hardt et al.,
1998; Rudolph et al., 1999). SopE, one of the most active
exchange factors studied to date (Friebel and Hardt, 2000;
Rudolph et al., 1999), quickly catalyzed the exchange of
the bound GDP of Rac1, RhoA, and Cdc42 with the
mant-GTP (Figure 5B). Incubation of Rac1 or RhoA with
increasing amounts of YpkA leads to a dose-dependent
decrease in exchange when challenged by SopE (Fig-
ure 5B). In contrast, YpkA was unable to inhibit exchange
in Cdc42 catalyzed by SopE (Figure 5C). As was observed
with the intrinsic nucleotide exchange of Rac1 and RhoA,
the triple mutant of YpkA was completely inactive againstSopE. We therefore conclude that the YpkA C-terminal
domain is a potent inhibitor of nucleotide exchange for
Rac1 and RhoA in vitro.
We then sought to establish the in vivo significance of
binding to RhoA and Rac1, and thereby, presumably,
the biological significance of the GDI-like activity of
YpkA. To address this, we transfected cultured human
intestinal epithelial cells (Henle407) with the following six
YpkA constructs: 1–732 (wild-type), 1–732 (K272A, kinase
active site mutant), 1–732 (Contact A mutant), 1–732
(K272A + Contact A mutant), 434–732, and 434–732 Con-
tact A mutant (Experimental Procedures). After 24 hr the
cells were immunostained for the YpkA constructs withCell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc. 873
Figure 4. YpkA Mimics the Binding of
Host Cell GDIs
(A) Structural alignment between YpkA-Rac1
with the RhoGDI-1(a)-Rac1 and the RhoGDI-2
(LyGDI)-Rac2 complexes at Switch I. YpkA is
indicated in orange, Rac1 bound to YpkA is
indicated in blue, the RhoGDI-1(a) Rac1
structure in red and the RhoGDI-2(LyGDI)
Rac2 structure in tan. The GDP molecule from
the YpkA-Rac1 complex structure is shown
in blue.
(B) Structural alignment between the YpkA-
Rac1, RhoAGDP, SptP-Rac1, and RhoGDI-2
(LyGDI)-Rac2 complexes at Switch II. The
YpkA complex is indicated in green, the
RhoA-GDP structure in blue, the SptP-Rac1-
GDP-AlF3 complex in red, and the RhoGDI-2
(LyGDI)-Rac2 complex in tan. The residues at
the N and C terminus of the region in Rac1
shown are labeled.
(C) The conserved interactions of YpkA and
GDI proteins with Rho family GTPases is
shown. Both Switch I and Switch II are indicated with the secondary structural elements of the YpkA-Rac1 structure drawn above. Residues involved
in hydrogen bonding are drawn in red, and those residues making hydrophobic or Van der Waals contacts are highlighted in yellow. Similar interac-
tions between YpkA and the RhoGDI proteins are boxed.antibodies against an N-terminal FLAG epitope (Experi-
mental Procedures) and the cytoskeleton visualized by
staining with Rhodamine Phalloidin. As has been reported
(Ha¨kansson et al., 1996; Juris et al., 2000; Nejedlik et al.,
2004), transfection with wild-type YpkA induces extensive
cytoskeletal disruption, leading to a loss of actin stress
fibers and a distortion in the cellular morphology. In fact,
transfection of YpkA into mammalian cells induces two
observable effects, the first causing the disappearance
of actin stress fibers and the second resulting in severe
cellular deformation in addition to the loss of stress fiber
formation (Figure 6). This cellular deformation has been
described as a ‘‘rounding up’’ of the cells but maintaining
focal adhesions (Juris et al., 2000). Full-length YpkA
shows the ability to both prevent stress fiber formation
and causes a large number of the Henle cells to lose their
shape, resulting in the described cellular deformation or
‘‘wild-type’’ effect (Figure 6B). Transfection with the N-ter-
minal deletion construct YpkA (434–732), which lacks the
serine-threonine kinase domain, results in an attenuated
or ‘‘intermediate’’ phenotype. YpkA (434–732) is able to
cause the disappearance of actin stress fibers in most
cells, although its ability to cause cellular deformation is
reduced as compared to the wild-type construct
(Figure 6A). The YpkA (434–732) Contact A mutant, which
is deficient for both Rac1 and RhoA binding, in addition to
GDP dissociation inhibition in vitro, leads to a complete
loss of cytoskeletal disruption (Figure 6B).
In the context of the full-length protein, these same mu-
tations are intriguing. To begin, YpkA with the kinase ac-
tive site mutation K272A is only slightly attenuated in cyto-
skeletal disruption, losing most of the wild-type effect but
maintaining a significant amount of the intermediate effect
(Figure 6A). In fact, this mutant is nearly identical in its ef-
fect on cells to the deletion of the entire kinase domain. In874 Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc.contrast, the YpkA Contact A mutant, defective for binding
to Rac1 and RhoA (and defective for GDI-like activity)
causes a very low level of cytoskeletal alterations, and
adding to this mutant, the K272A kinase mutation does
not appreciably change the phenotype. Although the
full-length YpkA Contact A mutant and the K272A Contact
A mutant do not cause significant cytoskeletal alterations,
they are observed to localize to the membrane (Figure 6B,
data not shown). As both the 434–732 construct and the
434–732 Contact A mutant are seen uniformly distributed
throughout the cell, this supports the previously reported
results that membrane localization is not dependent
upon small GTPase binding and may be dependent
upon a signal in the N terminus of YpkA (Dukuzumuremyi
et al., 2000).
Altogether, these results strongly suggest that the C-
terminal, GDI-like activity of YpkA is the more significant
contributor to cytoskeletal effects. The kinase domain
does appear to work synergistically with the GDI-like do-
main, however, as evinced in both the reduced wild-type
effect of the kinase active site mutant as well as the com-
plete loss of activity in the YpkA (434–732) GDI (Contact A)
mutant. Interestingly, the double mutant of kinase and GDI
does not completely abolish cytoskeletal effects, perhaps
due to residual kinase activity present in the K272A muta-
tion (Dukuzumuremyi et al., 2000; Juris et al., 2000).
In order to establish the relevance of these biochemical
and cell biological data to infection, we examined the vir-
ulence phenotypes of Y. pseudotuberculosis ypkA mu-
tants in a mouse infection assay. Two such mutants
were tested, a ypkA null mutant, in which the entire ypkA
reading frame was deleted, and a ypkA Contact A mutant,
in which the Tyr591Ala, Asn595Ala, and Glu599Ala codon
substitutions were introduced onto the virulence plasmid.
Analysis by SDS-PAGE of the Yops secreted by these
Figure 5. YpkA Inhibits Nucleotide Exchange in Rac1 and RhoA
The intrinsic and GEF catalyzed rate of mant-GTP exchange into the small GTPases Rac1, RhoA, and Cdc42 was monitored as described in Exper-
imental Procedures. The left column shows the intrinsic rate inhibition data, and the right column shows the rate inhibition data when challenged with
the Salmonella GEF SopE. Panel (A) is Rac1, panel (B) is RhoA, and panel (C) is Cdc42. The experiments are shown with the increase of relative
fluorescence units (RFU) over time in seconds. The labels are described in a legend below the figure, where 1.53 and 33 are relative molar concen-
trations of YpkA or YpkA Contact A mutant above the small GTPase. Error bars (panels A-C) represent the standard deviation (from the mean value
plotted) calculatd from a minimum of three independent experiments.Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc. 875
Figure 6. GDI Activity Is Critical for YpkA
to Promote Cytoskeletal Alterations
(A) The bar graph represents the percentage of
transfected cells with cytoskeletal alterations
and the contribution of the observed wild-
type phenotype and the observed intermediate
phenotype to the total percentage. The wild-
type phenotype is indicated in gray and the
intermediate phenotype in white. Bacterial Al-
kaline Phosphatase, BAP, is the negative con-
trol; 1–732 is wild-type YpkA; 1–732 K272A is
a kinase inactive mutant of YpkA; 1–732 Con-
tact A is YpkA with the Contact A mutant;
1–732 K272A Contact A is the kinase inactive
mutant plus the Contact A mutant; 434–732 is
the crystallized construct; 434–732 Contact A
is the Contact A mutant (RhoA/Rac1 binding
deficient structure-based mutant). Error bars
(panels A-C) represent the standard deviation
(from the mean value plotted) calculated from
a minimum of three independent experiments.
(B) Examples of the visualization of YpkA by the
immunostaining of transfected Henle407 cells.
Each of the three observed phenotypes is
shown with staining for both the epitope,
FLAG-tagged YpkA and for the actin cytoskel-
eton (Experimental Procedures). Each row is
labeled by the construct transfected. The first
column shows the presence of expression of
the FLAG-tagged YpkA constructs and is col-
ored in green. The second column shows the
immunostaining of the actin cytoskeleton by
rhodamine phalloidin in red, and the last
column is the overlay of the fluorescent signals.strains showed that the null mutant did not secrete YpkA
protein, while the Contact A mutant secreted a full-length
polypeptide (Figure S5A). Immunoblot analysis of se-
creted Yops showed that YopT and YopE were secreted
at native levels by the null mutant and Contact A mutant
(Figures S5B and S5C). In addition, the results of a HeLa
cell rounding assay indicated that the null mutant and
Contact A mutant translocated YopT and YopE into host
cells at normal levels (Figure S6). Mice were infected intra-
gastrically with one of the mutants, or the isogenic paren-
tal strain, and the animals were monitored for survival
over a 14 day period. As shown in Figure 7, all eight876 Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Incmice infected with the wild-type strain succumbed to the
infection by day 9, while only two mice infected with the
Contact A mutant died, one on day 7 and one on day 12.
The survival curves for the mice infected with the wild-
type or Contact A mutant strains were significantly differ-
ent (P = 0.0003), as determined by a logrank test. Interest-
ingly, all mice infected with the ypkA null mutant died by
day 8 (Figure 7), a survival rate not significantly different
from the wild-type control (P = 0.7333). Other groups
studying pathogenesis of Yersinia ypkA null mutants in
mouse infection assays have recently reported similar
findings, in that strains lacking the ypkA gene appear to.
be as virulent as parental strains (Logsdon and Mecsas,
2003; Tru¨lzsch et al., 2004). In contrast, Y. pseudotuber-
culosis strains that express the altered YpkA protein
lacking the GDI activity are clearly attenuated for virulence
(Figure 7). Taken together, these findings indicate that the
GDI activity of YpkA is critical for Yersinia virulence.
DISCUSSION
A Host GDI Mimic Crucial to Virulence in Yersinia
Virulence in Yersinia pseudotuberculosis depends upon
the translocated virulence factor YpkA (Galyov et al.,
1993), a protein that is very highly conserved in the plague
pathogen, Yersinia pestis. Despite the known importance
to virulence, little has been forthcoming in understanding
the mechanism of activity of YpkA. This has been particu-
larly true of the C-terminal domain of the protein, which,
while known to bind Rho GTPases, has remained enig-
matic in terms of function.
The cocrystal structure of a C-terminal domain of YpkA
and Rac1 reveals that this bacterial virulence factor is
a mimic of host Rho-family GDI proteins in its binding to
the GTPase and also in its ability to inhibit nucleotide ex-
change. Loss-of-contact mutations in YpkA that impair
Rac1 and RhoA binding abolish this GDI-like activity,
and severely diminish the cytoskeletal disruption induced
by this domain. Furthermore, these mutations severely de-
crease Yersinia virulence in a mouse model of infection.
Altogether, these data strongly suggest that YpkA mimics
host GDI proteins by acting as an ‘‘off switch’’ to modulate
the Rac1-associated signaling pathways that regulate
host cytoskeletal structure.
Collaborative Inactivation of Small GTPases
by Yersinia Outer Proteins
Interestingly, despite the fact that YpkA mimics key as-
pects of GDI function, it does not possess all the activities
Figure 7. The GDI Activity of YpkA Is Critical for Yersinia
Virulence
Groups of mice were infected intragastrically with 53 109 CFU of wild-
type Y. pseudotuberculosis, a ypkA null mutant, or a ypkA Contact A
mutant. Survival of the mice was recorded over a 14 day period.
Results shown are compiled from two independent experiments
that were performed with groups of four mice (logrank value of P =
0.0003 between the wild-type and Contact A mutant curves).of its host cell counterparts. Host cell RhoGDIs are also
able to slow the intrinsic rate of GTP hydrolysis by small
GTPases and, more importantly, have a specialized do-
main that the protein uses to bind the isoprenylated tail
of small GTPases to remove them from the cell mem-
brane. Although YpkA can bind to both the GDP and
GTP conformations of RhoA and Rac1 (Dukuzumuremyi
et al., 2000) and inhibit nucleotide release, it only has
a moderate effect on the intrinsic rate of GTP hydrolysis
(data not shown). Moreover, YpkA does not possess any
clear analog of the b sheet motif necessary to bind an iso-
prenyl group, and it seems likely that YpkA has no such
function. This may in fact be reasonable, as another Yersi-
nia virulence factor that is translocated into host cells
along with YpkA, YopT, removes any selective pressure
for such a membrane removing GDI-like activity. This is
because YopT, a cysteine protease that specifically
cleaves off the C-terminal tail residues of the RhoGTPases
Cdc42, Rac1, and RhoA, removes the small GTPases
from the membrane in a highly efficient manner (Shao
et al., 2002). Moreover, Yersinia also translocates into
host cells YopE, a GAP or GTPase activating protein es-
sential for virulence, that quickly catalyzes the hydrolysis
of GTP bound to small GTPases of the Rho family (Black
and Bliska, 2000). Therefore, between YpkA and YopT,
two of the physiological effects of a RhoGDI can be reca-
pitulated. The final activity seen in many host RhoGDIs,
the inhibition of GAP activity on the RhoGTPases, would
be counterproductive and interfere with the function of
YopE. Thus, YpkA appears to be perfectly engineered to
work in concert with YopE and YopT.
Synergy between Kinase and GDI Domains
Our data suggest an explanation of previous results
obtained in the work by Juris et al., 2000. In their research,
HeLa cells were transfected with vectors expressing wild-
type YpkA, a YpkA kinase inactivated mutant (K269A of
Yersinia entercolitica YopO, equivalent to K272A of Yersi-
nia pseudotuberculosis YpkA), and a C-terminal deletion
construct that prevented kinase activity, reporting that,
compared to the wild-type phenotype, the kinase inactive
mutant exhibited an intermediate phenotype where actin
stress fiber formation was disrupted, but the actin micro-
filament system partially remained. This observation is
consistent with our observations that YpkA (434–732)
alone, as well as full-length YpkA K272A, are sufficient
to disrupt stress fiber formation as well as to cause a
low level of cellular deformation. Results with the C-
terminal deletion constructs show that no cytoskeletal
disruption activity is observed, although they contain the
elements necessary for Rac1/RhoA binding. Our bio-
chemical and structural results suggest that this may be
explained by the aggregated and misfolded nature of
these constructs (Figure S1) and not simply a lack of bind-
ing to actin. Taking into account our observations and the
work by Juris et al., 2000, it is apparent that the full effect
of YpkA function is achieved by both the kinase activity
and the GDI activity of the C-terminal domain, althoughCell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc. 877
our point mutants in cell culture argue that the GDI-like
activity is the greater contributor.
Virulence Phenotypes of ypkA Mutants
In the initial work that reported the identification of YpkA,
Galyov et al., 1993 demonstrated that two different Y.
pseudotuberculosis ypkA mutants were attenuated for vir-
ulence in a mouse infection model. One attenuated mutant
resulted from an in-frame deletion of ypkA codons 207–
388, which removed a major portion of the kinase domain
and produced a protein that was secreted by the T3SS but
lacked kinase activity (Galyov et al., 1993). The other mu-
tant produced a protein truncated after residue 548 that
was also competent for secretion by the T3SS (Galyov
et al., 1993). Taken at face value, these results suggested
that both the kinase activity and a C-terminal region of
YpkA were important for Yersinia virulence. However, it re-
mained unclear how the C-terminal region of YpkA con-
tributed to Yersinia virulence. Moreover, in recent studies,
little or no role for YpkA in virulence could be found when
Yersinia mutants containing a larger in-frame deletion of
ypkA (codons 21–712) (Logsdon and Mecsas, 2003), or
a complete deletion of the yopO reading frame (Tru¨lzsch
et al., 2004), were utilized in mouse infection assays. By
constructing a Y. pseudotuberculosis point mutant specif-
ically defective for GDI function, we now demonstrate that
this activity within the C-terminal domain of YpkA is critical
for Yersinia virulence. We further confirmed the findings
that mutations that remove most, or all, of the ypkA read-
ing frame do not lead to attenuation of virulence in a mouse
infection model (Logsdon and Mecsas, 2003; Tru¨lzsch
et al., 2004). One possible explanation for these results
is that null mutations in ypkA result in increased transloca-
tion of other Yop virulence factors in vivo, which compen-
sates for the loss of YpkA function. If true, this type of
phenomenon further underscores the power and impor-
tance of employing mutations that ablate the activity,
and not the expression, of a suspected bacterial virulence
determinant.
A Widespread Theme of Host Mimicry
It is becoming increasingly clear that a common strategy
used by bacterial pathogens to modulate host cell biology
is the mimicry of eukaryotic biochemical processes
(Stebbins and Gala´n, 2001). This has been especially true
of virulence factors that target the Rho GTPases in order
to manipulate host cytoskeletal structure. We have pre-
sented data here that the Yersinia virulence factor YpkA,
in addition to its host-like serine/threonine kinase activ-
ity, possesses an additional host mimicry by harboring
key functions of the RhoGDI proteins, preventing nucleo-
tide exchange in RhoA and Rac1 and thereby disrupting
the host cytoskeleton. This fascinating interaction we
show to exert a virulence effect, revealing another exam-
ple of host mimicry in the virulence strategies of bacterial
pathogens.878 Cell 126, 869–880, September 8, 2006 ª2006 Elsevier Inc.EXPERIMENTAL PROCEDURES
Cloning, Mutagenesis, and Protein Purification
The Y. pseudotuburculosis YpkA gene was cloned from the Yersinia
virulence plasmid as an N-terminal fusion with glutathione-S-transfer-
ase (GST). To create the YpkA mutants, the amino acid substitutions
were introduced by PCR using primers containing the appropriate
base changes and subsequent removal of the template plasmid by
digestion with Dpn I prior to transformation and verified by DNA
sequencing. YpkA clones were transformed into BL21 (DE3) cells,
and expression was induced with 1mM IPTG for 16 hr at 20C. YpkA
constructs were affinity purified using a glutathione-sepharose resin,
separated from GST by site-specific proteolytic cleavage and further
purified by ion exchange and gel filtration chromatography.
Crystallography
YpkA (434–732) was reductively methylated following published proto-
cols (Rypniewski et al., 1993) and crystallized at 4C by hanging drop
vapor diffusion using a 1:1 mixture of protein and well solution, which
consisted of 100 mM CAPs pH 10.5, 140–180 mM NaCl, and 16% to
18% PEG1500. Rac1 was purified using a glutathione-sepharose
resin, separated from GST by site-specific proteolytic cleavage, and
further purified by ion exchange and gel filtration chromatography.
The complex between methylated YpkA (434–732), and Rac1 1–184
bound to GDP was formed by first combining purified YpkA with an ex-
cess of Rac1 and then by isolation by gel filtration chromatography,
and crystallized at 22C by hanging drop-vapor diffusion using a 1:1
or 3:2 mixture of complex and well solution, which consisted of
100 mM HEPES pH 6.5–7.5, and 5% to 8% PEGMME2000. Phases
for the monomer structure were determined using the anomalous
signal from selenomethionine-substituted protein crystals using the
SOLVE/RESOLVE package (Terwilliger, 2004). The partial model built
by RESOLVE was then rebuilt and initially refined using ARP/wARP
(Perrakis et al., 1999) with the native data set. The model generated
by ARP/wARP was then refined using REFMAC5 (Murshudov et al.,
1997) from the CCP4 suite of programs (CCP4, 1994; Potterton
et al., 2003). The final model has an R/Rfree of 20.9/23.8, with 96.4%
of the residues in the most favored regions of the Ramchandran plot
with no outliers. For the YpkA (434–732) and Rac1 1–184 GDP complex
phases were determined by molecular replacement (search model
1MH1). The solution was then refined using REFMAC5 (Murshudov
et al., 1997) from the CCP4 suite of programs (1994; Potterton et al.,
2003; Winn et al., 2001, 2003). The final model has an R/Rfree of
22.4/25.9.
Binding and Exchange Assays
The complex between YpkA (434–732) and Rac1 (1–184) was formed
by first combining purified YpkA with an excess of Rac1, examining by
gel filtration chromatography, and finally visualizing by SDS-PAGE.
The Contact A mutant and Contact B mutant were purified as de-
scribed for YpkA (434–732), and the complex with Rac1 was formed
and analyzed as described for YpkA (434–732). Binding experiments
with RhoA (F25N 1–181) and Cdc42 (1–184) were carried out in the
same manner as Rac1. Both RhoA and Cdc42 were purified by GST
affinity chromatography followed by gel filtration. Purified Rac1 or
RhoA was incubated alone with buffer (20 mM Tris, pH 7.5, 50 mM
NaCl, 5 mM MgCl2) or with purified YpkA (434–732), YpkA (434–732)
Contact A mutant for 10 min on ice. Both YpkA (434–732) and YpkA
(434–732) Contact A mutant were added in either a 1.5-fold or in a
3-fold molar ratio access of Rac1. Purified Cdc42 was incubated alone
with buffer or with purified YpkA (434–732) in a 3-fold molar ratio
access. To initiate the intrinsic exchange reaction, the stock incuba-
tions were then added to reaction buffer (20 mM Tris, pH 7.5, 50 mM
NaCl, 5 mM MgCl2, and mant-GTP) resulting in a final concentration
of Rac1 at 40 mM and mant-GTP at 100 mM. Reactions were then trans-
ferred to a 96-well plate and left for 5 min to bring to room temperature.
The fluorescence of each reaction was measured every 5 min for a total
of 1 hr using a SpectraMax GeminiXS fluorimeter from Molecular De-
vices. An excitation wavelength of 355 nm and an emission wavelength
of 448 nm with a cutoff of 435 nm was used to detect the presence of
bound mant-GTP. SopE was added to each reaction after the 5 min
incubation to room temperature at a final concentration of 0.22 mM
for Rac1 or RhoA and 0.04 mM for Cdc42.
Transfections
YpkA constructs 1–732, 434–732, and 434–732 Contact A mutant
(Tyr591A, Asn595A, Glu599A), were cloned into the pFLAG-CMV-4
mammalian expression vector using the restriction sites NotI and
XbaI resulting in N-terminally tagged constructs. Henle407 cells were
grown to confluence in DMEM media containing 10% Fetal Bovine Se-
rum (FBS) and penicillin/streptomycin. The cells were then transferred
to six-well tissue culture dishes containing a glass coverslip. Approx-
imately 200,000 cells were added to each well with a total volume of
2 ml and grown overnight. The transfections were carried out using
the Geneporter2 reagent and protocol (Genlantis). A total of 6 mg of
DNA was added to each reaction, and reactions were performed in
triplicate. Reactions were allowed to proceed for 24 hr before being
fixed and stained. Cells were fixed with 3% Formaldyde, permeabi-
lized with 0.5% Triton, and blocked with 3% BSA in PBS before expo-
sure to antibodies. The YpkA constructs were visualized by primary
antibody staining with mouse a-FLAG antibody (Sigma) and then by
the secondary Alexa-Fluor goat a-mouse antibody (Molecular Probes).
The actin cytoskeleton was visualized by staining with Rhodamine
Phalloidin (Molecular Probes). To quantify the effect of each construct
on the host cytoskelon each reaction was counted blind and in tripli-
cate. For each reaction, between 75 and 200 transfected cells were
counted for each of the triplicate reactions (a total of 225–450 cells
for each construct) and the state of their cytoskeleton scored as
wild-type or intermediate effect. The cells were visualized by the use
of an Axioplan2 upright microscope with Attoattic fluorescent filters
and a Hammatsu Digital Camera or by the use of a Zeiss LSM510
confocal microscope.
Yersinia Strains and Mouse Infection Assays
IP2777 is a virulent serogroup O1 strain of Y. pseudotuberculosis ob-
tained from Michel Simonet (Simonet and Falkow, 1992). The LD50
of IP2777 in C57BL/6 mice challenged intragastrically is 5 3 108
CFU. YpkA null and Contact A mutants were constructed as described
in the Supplemental Experimental Procedures. Two independent
mouse infection experiments were carried out, and the results pre-
sented are compiled from the two experiments. Eight-week-old female
C57BL/6 mice (Taconic) were challenged by the intragastric route us-
ing a 20 gauge feeding needle. Bacterial inocula were prepared from
cultures grown in Luria Broth (LB) with shaking at 26C. Bacteria
were inoculated into LB, grown overnight, and subcultured in LB to
an OD600 of 0.1. After a second overnight growth, the cultures were
centrifuged, the bacterial pellets were washed once in Hank’s bal-
anced salt solution (HBSS), and suspended HBSS to yield 5 3 109
CFU per 0.2 ml. C57BL/6 mice were fasted for 18 hr prior to infection.
Groups of four animals were infected with 0.2 ml of suspended bacte-
ria (a dose equivalent to 10 LD50s). Infected mice were provided food
and water and carefully observed three times a day over a 14 day
period. Mice exhibiting severe signs of disease (ruffled fur, hunched
posture, and immobility) were humanely euthanized by CO2 inhalation.
Survival curves were plotted using Prism (GraphPad) and analyzed for
significant differences using the Mantel-Haenszel logrank test. These
experiments were carried out in compliance with protocols approved
by the IACUC at Stony Brook University.
Supplemental Data
Supplemental Data include six figures, two tables, and references and
can be found with this article online at http://www.cell.com/cgi/
content/full/126/5/869/DC1/.ACKNOWLEDGMENTS
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